BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Colorectal cancer AND COL2A1, SEDC, MGC131516, COL11A3, AOM, ANFH, ENSG00000139219, 1280 AND Treatment
228 results:

  • 1. Tropomyosin 2 Regulates Tumor Cell Proliferation, Immune Suppression, and Activation of the JNK Signaling Pathway in Colitis-Associated cancer (CAC).
    Sun A; Ge J; Ding K; Gao Z; Zhang Y
    Discov Med; 2024 Apr; 36(183):778-787. PubMed ID: 38665026
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Esculin induces endoplasmic reticulum stress and drives apoptosis and ferroptosis in colorectal cancer via PERK regulating eIF2α/CHOP and Nrf2/HO-1 cascades.
    Ji X; Chen Z; Lin W; Wu Q; Wu Y; Hong Y; Tong H; Wang C; Zhang Y
    J Ethnopharmacol; 2024 Jun; 328():118139. PubMed ID: 38561058
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Mitotic Spindle Positioning (MISP) Facilitates colorectal cancer Progression by Forming a Complex with Opa Interacting Protein 5 (OIP5) and Activating the JAK2-STAT3 Signaling Pathway.
    Hiura K; Watanabe M; Hirose N; Nakano K; Okamura T; Sasaki H; Sasaki N
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474305
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. Entero-toxigenic
    Yang J; Wang X; Hu T; Huang H; Chen G; Jin B; Zeng G; Liu J
    Cell Cycle; 2024 Jan; 23(1):70-82. PubMed ID: 38273425
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Therapeutic effects of coptisine derivative EHLJ7 on colorectal cancer by inhibiting PI3K/AKT pathway.
    Chai C; Tang X; Chi X; Li X; Zhang H; Wu L
    Cell Signal; 2024 Apr; 116():111053. PubMed ID: 38224723
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Deletion of IL-27p28 induces CD8 T cell immunity against colorectal tumorigenesis.
    Li P; Pu S; Yi J; Li X; Wu Q; Yang C; Kang M; Peng F; Zhou Z
    Int Immunopharmacol; 2024 Feb; 128():111464. PubMed ID: 38224627
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Chronic Stress Dampens Lactobacillus Johnsonii-Mediated Tumor Suppression to Enhance colorectal cancer Progression.
    Cao Q; Zhao M; Su Y; Liu S; Lin Y; Da H; Yue C; Liu Y; Jing D; Zhao Q; Liu N; Du J; Zuo Z; Fu Y; Chen A; Birnbaumer L; Yang Y; Dai B; Gao X
    Cancer Res; 2024 Mar; 84(5):771-784. PubMed ID: 38190716
    [TBL] [Abstract] [Full Text] [Related]  

  • 8. Bifidobacterium longum SX-1326 ameliorates gastrointestinal toxicity after irinotecan chemotherapy via modulating the P53 signaling pathway and brain-gut axis.
    Yue F; Zeng X; Wang Y; Fang Y; Yue M; Zhao X; Zhu R; Zeng Q; Wei J; Chen T
    BMC Microbiol; 2024 Jan; 24(1):8. PubMed ID: 38172689
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Ephrin B3 exacerbates colitis and colitis-associated colorectal cancer.
    Qiao Z; Liao M; Xiao M; Luo S; Wang K; Niu M; Jiang H; Sun S; Xu G; Xu N; Xu Q; Liu Y
    Biochem Pharmacol; 2024 Feb; 220():116004. PubMed ID: 38142837
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Dihydroartemisinin inhibits the development of colorectal cancer by GSK-3β/TCF7/MMP9 pathway and synergies with capecitabine.
    Dai X; Chen W; Qiao Y; Chen X; Chen Y; Zhang K; Zhang Q; Duan X; Li X; Zhao J; Tian F; Liu K; Dong Z; Lu J
    Cancer Lett; 2024 Feb; 582():216596. PubMed ID: 38101610
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. Chemopreventive Effects of Polysaccharides and Flavonoids from Okra Flowers in Azomethane/Dextran Sulfate Sodium-Induced Murine Colitis-Associated cancer.
    Deng Y; Huang X; Chen X; Wang M; Tian L; Zhou H; Yang W; He F; Yin W
    Nutrients; 2023 Nov; 15(22):. PubMed ID: 38004214
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Loss of SETD2 aggravates colorectal cancer progression caused by SMAD4 deletion through the RAS/ERK signalling pathway.
    Ma C; Liu M; Feng W; Rao H; Zhang W; Liu C; Xu Y; Wang Z; Teng Y; Yang X; Ni L; Xu J; Gao WQ; Lu B; Li L
    Clin Transl Med; 2023 Nov; 13(11):e1475. PubMed ID: 37962020
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Murine models of colorectal cancer: the azoxymethane (aom)/dextran sulfate sodium (DSS) model of colitis-associated cancer.
    Dzhalilova D; Zolotova N; Fokichev N; Makarova O
    PeerJ; 2023; 11():e16159. PubMed ID: 37927787
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. Yogurt Prevents Colitis-Associated colorectal cancer in Mice.
    Li X; Yan Y; Du X; Zhang H; Li H; Chen W
    Mol Nutr Food Res; 2023 Dec; 67(24):e2300444. PubMed ID: 37897323
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. Berberrubine is a novel and selective IMPDH2 inhibitor that impairs the growth of colorectal cancer.
    He X; Cui J; Ma H; Abuduaini N; Huang Y; Tang L; Wang W; Zhang Y; Wang Y; Lu W; Feng B; Huang J
    Biochem Pharmacol; 2023 Dec; 218():115868. PubMed ID: 37871880
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. A network pharmacology approach and experimental validation to investigate the anticancer mechanism of Qi-Qin-Hu-Chang formula against colitis-associated colorectal cancer through induction of apoptosis via JNK/p38 MAPK signaling pathway.
    Wu Y; Fang Y; Li Y; Au R; Cheng C; Li W; Xu F; Cui Y; Zhu L; Shen H
    J Ethnopharmacol; 2024 Jan; 319(Pt 3):117323. PubMed ID: 37852337
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Ochratoxin A promotes chronic enteritis and early colorectal cancer progression by targeting Rinck signaling.
    Liu X; Yan C; Chang C; Meng F; Shen W; Wang S; Zhang Y
    Phytomedicine; 2024 Jan; 122():155095. PubMed ID: 37844381
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. TRIP6 disrupts tight junctions to promote metastasis and drug resistance and is a therapeutic target in colorectal cancer.
    Gou H; Wong CC; Chen H; Shang H; Su H; Zhai J; Liu W; Liu W; Sun D; Wang X; Yu J
    Cancer Lett; 2023 Dec; 578():216438. PubMed ID: 37827326
    [TBL] [Abstract] [Full Text] [Related]  

  • 19.
    Zhang L; Ji Q; Chen Q; Wei Z; Liu S; Zhang L; Zhang Y; Li Z; Liu H; Sui H
    Int J Biol Sci; 2023; 19(14):4393-4410. PubMed ID: 37781044
    [No Abstract]    [Full Text] [Related]  

  • 20. Nuclear translocation of thioredoxin-1 promotes colorectal cancer development via modulation of the IL-6/STAT3 signaling axis through interaction with STAT3.
    Wu A; Fang D; Liu Y; Shi X; Zhong Z; Zhou B; Ye L; Sun X; Jiang L
    Theranostics; 2023; 13(14):4730-4744. PubMed ID: 37771783
    [No Abstract]    [Full Text] [Related]  


    [Next]

    of 12.